View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Optics News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 15, 2024
2 min read
Save

Control myopia in children to prevent retinal problems later in life

Control myopia in children to prevent retinal problems later in life

NEW YORK — Most parents are unaware of the complications of high myopia as well as the potential to control it in children, Janelle Davison, OD, said at Vision Expo East.

SPONSORED CONTENT
March 07, 2024
1 min read
Save

Structure of green space may affect myopia progression in school-aged children

Structure of green space may affect myopia progression in school-aged children

An increase in green space morphology was correlated with slowing myopia progression in primary school-aged children, according to a study published in JAMA Ophthalmology.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
March 01, 2024
1 min watch
Save

VIDEO: Optometrists already have tools to manage concussion patients

VIDEO: Optometrists already have tools to manage concussion patients

ATLANTA — Primary care optometrists can manage patients with mild traumatic brain injury in their practices without the need for vision therapy equipment, Heidi Bell, OD, FAAO, FCOVD, said at SECO 2024.

SPONSORED CONTENT
February 26, 2024
2 min read
Save

Nearly 7 of 10 U.S. adults report digital eye strain symptoms

Nearly 7 of 10 U.S. adults report digital eye strain symptoms

An increase in screen time has led to a rise in digital eye strain in the U.S., according to a report released by CooperVision.

SPONSORED CONTENT
February 21, 2024
1 min read
Save

Only 14% of US children that get eye exams are 7 years or younger

Only 14% of US children that get eye exams are 7 years or younger

Children in the U.S. are not receiving timely management for refractive error or ocular conditions, according to research conducted by CooperVision and presented at the 2024 Global Specialty Lens Symposium.

SPONSORED CONTENT
February 16, 2024
1 min read
Save

SightGlass receives FDA breakthrough designation for spectacle lenses that slow myopia

SightGlass receives FDA breakthrough designation for spectacle lenses that slow myopia

The FDA has granted breakthrough device designation to SightGlass Vision’s diffusion optics technology spectacle lenses, which are designed to slow myopia progression in children.

SPONSORED CONTENT
February 12, 2024
1 min read
Save

Spiral-shaped lens mimics progressives with clarity across different distances, lighting

Spiral-shaped lens mimics progressives with clarity across different distances, lighting

A team of researchers in France has developed a freeform, spiral-shaped lens designed to maintain clear focus at different distances and under varying light conditions, according to a research article published in Optica.

SPONSORED CONTENT
January 23, 2024
1 min read
Save

MiSight 1 day contact lenses delay axial growth by up to 4 years

MiSight 1 day contact lenses delay axial growth by up to 4 years

Treatment with MiSight 1 day contact lenses reduced axial growth in children by 0.52 mm compared with predicted accumulated growth of untreated eyes, according to 6-year data published in Ophthalmic and Physiological Optics.

SPONSORED CONTENT
January 19, 2024
1 min read
Save

Eyenovia reacquires rights to MicroPine ophthalmic atropine spray in US, Canada

Eyenovia reacquires rights to MicroPine ophthalmic atropine spray in US, Canada

Eyenovia has announced the reacquisition of development and commercialization rights to MicroPine, an investigational 8 µL ophthalmic atropine spray being evaluated for pediatric progressive myopia.

SPONSORED CONTENT
January 04, 2024
1 min read
Save

FDA agrees to LYNX-2 trial of phentolamine ophthalmic solution for poor night vision

FDA agrees to LYNX-2 trial of phentolamine ophthalmic solution for poor night vision

Ocuphire Pharma has received agreement from the FDA under a special protocol assessment for its LYNX-2 phase 3 trial, a study of phentolamine ophthalmic solution for treatment of reduced visual acuity under low light conditions.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails